Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0SD3Q
|
|||
Former ID |
DIB001449
|
|||
Drug Name |
GIDAZEPAM
|
|||
Synonyms |
2-(7-Bromo-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-1-yl)acetic acid hydrazide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Anxiety disorder [ICD-11: 6B00-6B0Z; ICD-10: R45.0] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H15BrN4O2
|
|||
Canonical SMILES |
C1C(=O)N(C2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=C3)CC(=O)NN
|
|||
InChI |
1S/C17H15BrN4O2/c18-12-6-7-14-13(8-12)17(11-4-2-1-3-5-11)20-9-16(24)22(14)10-15(23)21-19/h1-8H,9-10,19H2,(H,21,23)
|
|||
InChIKey |
XLGCMZLSEXRBSG-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 129186-29-4
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
1916794, 6411411, 10239864, 11215436, 15327299, 26659559, 29302411, 48267605, 49883940, 53245159, 57339845, 58024289, 81093088, 87798617, 92219774, 104414595, 105569760, 124952771, 130894749, 135076594, 136000430, 137140687, 143970693, 162385696, 163305923, 164235719, 170045064, 179195793, 184526732, 198961149, 227258882, 242361547, 252626281
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | GABA(A) receptor gamma-3 (GABRG3) | Target Info | Modulator | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Retrograde endocannabinoid signaling | ||||
GABAergic synapse | ||||
Morphine addiction | ||||
Nicotine addiction | ||||
Reactome | Ligand-gated ion channel transport | |||
GABA A receptor activation | ||||
WikiPathways | SIDS Susceptibility Pathways | |||
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | ||||
Iron uptake and transport |
References | Top | |||
---|---|---|---|---|
REF 1 | Discriminative effects of phenazepam and gidazepam in rats: comparison with other GABA-related drugs. Pharmacol Biochem Behav. 1999 Oct;64(2):397-401. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.